Loading
A phase 2 trial in triple-negative breast cancer, run by Tianjin Medical University Cancer Institute and Hospital, now recruiting.
A Single-Arm Phase Ⅱ Study of Fluzoparib Maintenance in Platinum-sensitive Advanced Triple-Negative Breast Cance is a phase 2, interventional study registered as NCT07321015 by Tianjin Medical University Cancer Institute and Hospital, with a registry enrolment figure of 72 participants, started 2026-01-20 and due to reach its primary completion in 2027-11-30. Interventions recorded: Fluzoparib Monotherapy. Conditions listed: Platinum-sensitive; TNBC, Triple Negative Breast Cancer; BRCA1/2 Mutation or Not. Triple-negative eligibility wording from the registry: "Histologically confirmed triple-negative breast cancer (TNBC; ER \<1%, PR \<1%, HER2-negative)". Sites: China. No results are recorded here; the registry entry is the source.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.